Member access

4-Traders Homepage  >  Shares  >  Euronext Bruxelles  >  UCB    UCB   BE0003739530

UCB (UCB)

299
Real-time Quote. Real-time Tradegate - 12/19 04:01:54 pm
65.835 EUR   +1.25%
3d agoDJUCB : Advent, Avista End Acquisition Agreement
11/13 UCB : Transparency notification of Vanguard Health Care Fund
11/12 UCB : Transparency notification of Vanguard Health Care Fund
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Bruxelles
12/15/2014 12/16/2014 12/17/2014 12/18/2014 12/19/2014 Date
63.66(c) 64.06(c) 63.4(c) 65.02(c) 65.79(c) Last
246 054 374 750 353 664 299 362 346 317 Volume
-1.71% +0.63% -1.03% +2.56% +1.18% Change
More quotes
Company
UCB SA is a biopharmaceutical company that engages in the research, development and commercialization of innovative drugs in the fields of central nervous system and immunology disorders.It focuses on the discovery and development of innovative medicines and solutions to transform the lives of... 
Sector
Pharmaceuticals
Calendar
02/25Earnings Release
More about the company
Surperformance© ratings of UCB
Trading Rating : Investor Rating :
More Ratings
Chart UCB
Duration : Period :
UCB Technical Analysis Chart | UCB | BE0003739530 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 3 446 M
EBIT 2014 481 M
Net income 2014 247 M
Debt 2014 1 255 M
Yield 2014 1,64%
Sales 2015 3 739 M
EBIT 2015 628 M
Net income 2015 359 M
Debt 2015 1 069 M
Yield 2015 1,84%
PER 2014 47,61
PER 2015 32,30
EV / Sales 2014 4,03x
EV / Sales 2015 3,67x
Capitalization 12 647 M
More Financials
Latest news on UCB
1d ago UCB : "Method for Producing Protein" in Patent Application Approval Process
3d agoDJUCB : Advent, Avista End Acquisition Agreement
12/05 UCB : Taps Cegedim Relationship Management Mobile Intelligence Cloud Platform
11/13 UCB : Transparency notification of Vanguard Health Care Fund
11/12 UCB : Transparency notification of Vanguard Health Care Fund
11/07 Belgium's UCB to sell generics unit for 964 million pounds
10/22 EXCLUSIVE- ADVENT, AVISTA NEAR DEAL : sources
10/21UCB SA : quaterly earnings release
More news
Sector news
46m ago JAZZ PHARMACEUTICALS : Receives FDA Approval For Intravenous Administration Of E..
1h ago CUBIST PHARMACEUTICALS : FDA OKs Cubist antibiotic for serious infections
1h ago CUBIST PHARMACEUTICALS : Announces FDA Approval of New Antibiotic ZERBAXA™..
More sector news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF